Pratz, K. W., Sato, T., Murphy, K. M., Stine, A., Rajkhowa, T., & Levis, M. (2010). FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. American Society of Hematology.

Pratz, Keith W., Takashi Sato, Kathleen M. Murphy, Adam Stine, Trivikram Rajkhowa, and Mark Levis. FLT3-mutant Allelic Burden and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML. American Society of Hematology, 2010.

Pratz, Keith W., et al. FLT3-mutant Allelic Burden and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML. American Society of Hematology, 2010.